JOINT FILING AGREEMENTJoint Filing Agreement • December 11th, 2018 • Broadfin Capital, LLC • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares, $0.01 nominal value per share, of Avadel Pharmaceuticals plc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
